271 related articles for article (PubMed ID: 26384369)
1. Whole-Genome Sequencing Suggests Schizophrenia Risk Mechanisms in Humans with 22q11.2 Deletion Syndrome.
Merico D; Zarrei M; Costain G; Ogura L; Alipanahi B; Gazzellone MJ; Butcher NJ; Thiruvahindrapuram B; Nalpathamkalam T; Chow EW; Andrade DM; Frey BJ; Marshall CR; Scherer SW; Bassett AS
G3 (Bethesda); 2015 Sep; 5(11):2453-61. PubMed ID: 26384369
[TBL] [Abstract][Full Text] [Related]
2. Rare Genome-Wide Copy Number Variation and Expression of Schizophrenia in 22q11.2 Deletion Syndrome.
Bassett AS; Lowther C; Merico D; Costain G; Chow EWC; van Amelsvoort T; McDonald-McGinn D; Gur RE; Swillen A; Van den Bree M; Murphy K; Gothelf D; Bearden CE; Eliez S; Kates W; Philip N; Sashi V; Campbell L; Vorstman J; Cubells J; Repetto GM; Simon T; Boot E; Heung T; Evers R; Vingerhoets C; van Duin E; Zackai E; Vergaelen E; Devriendt K; Vermeesch JR; Owen M; Murphy C; Michaelovosky E; Kushan L; Schneider M; Fremont W; Busa T; Hooper S; McCabe K; Duijff S; Isaev K; Pellecchia G; Wei J; Gazzellone MJ; Scherer SW; Emanuel BS; Guo T; Morrow BE; Marshall CR;
Am J Psychiatry; 2017 Nov; 174(11):1054-1063. PubMed ID: 28750581
[TBL] [Abstract][Full Text] [Related]
3. No evidence for the presence of genetic variants predisposing to psychotic disorders on the non-deleted 22q11.2 allele of VCFS patients.
Guipponi M; Santoni F; Schneider M; Gehrig C; Bustillo XB; Kates WR; Morrow B; Armando M; Vicari S; Sloan-Béna F; Gagnebin M; Shashi V; Hooper SR; Eliez S; Antonarakis SE
Transl Psychiatry; 2017 Feb; 7(2):e1039. PubMed ID: 28221368
[TBL] [Abstract][Full Text] [Related]
4. Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion.
Cleynen I; Engchuan W; Hestand MS; Heung T; Holleman AM; Johnston HR; Monfeuga T; McDonald-McGinn DM; Gur RE; Morrow BE; Swillen A; Vorstman JAS; Bearden CE; Chow EWC; van den Bree M; Emanuel BS; Vermeesch JR; Warren ST; Owen MJ; Chopra P; Cutler DJ; Duncan R; Kotlar AV; Mulle JG; Voss AJ; Zwick ME; Diacou A; Golden A; Guo T; Lin JR; Wang T; Zhang Z; Zhao Y; Marshall C; Merico D; Jin A; Lilley B; Salmons HI; Tran O; Holmans P; Pardinas A; Walters JTR; Demaerel W; Boot E; Butcher NJ; Costain GA; Lowther C; Evers R; van Amelsvoort TAMJ; van Duin E; Vingerhoets C; Breckpot J; Devriendt K; Vergaelen E; Vogels A; Crowley TB; McGinn DE; Moss EM; Sharkus RJ; Unolt M; Zackai EH; Calkins ME; Gallagher RS; Gur RC; Tang SX; Fritsch R; Ornstein C; Repetto GM; Breetvelt E; Duijff SN; Fiksinski A; Moss H; Niarchou M; Murphy KC; Prasad SE; Daly EM; Gudbrandsen M; Murphy CM; Murphy DG; Buzzanca A; Fabio FD; Digilio MC; Pontillo M; Marino B; Vicari S; Coleman K; Cubells JF; Ousley OY; Carmel M; Gothelf D; Mekori-Domachevsky E; Michaelovsky E; Weinberger R; Weizman A; Kushan L; Jalbrzikowski M; Armando M; Eliez S; Sandini C; Schneider M; Béna FS; Antshel KM; Fremont W; Kates WR; Belzeaux R; Busa T; Philip N; Campbell LE; McCabe KL; Hooper SR; Schoch K; Shashi V; Simon TJ; Tassone F; Arango C; Fraguas D; García-Miñaúr S; Morey-Canyelles J; Rosell J; Suñer DH; Raventos-Simic J; ; Epstein MP; Williams NM; Bassett AS
Mol Psychiatry; 2021 Aug; 26(8):4496-4510. PubMed ID: 32015465
[TBL] [Abstract][Full Text] [Related]
5. Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome.
Bassett AS; Marshall CR; Lionel AC; Chow EW; Scherer SW
Hum Mol Genet; 2008 Dec; 17(24):4045-53. PubMed ID: 18806272
[TBL] [Abstract][Full Text] [Related]
6. 22q11.2 deletion syndrome and schizophrenia.
Qin X; Chen J; Zhou T
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(11):1181-1190. PubMed ID: 33098288
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA Dysregulation, Gene Networks, and Risk for Schizophrenia in 22q11.2 Deletion Syndrome.
Merico D; Costain G; Butcher NJ; Warnica W; Ogura L; Alfred SE; Brzustowicz LM; Bassett AS
Front Neurol; 2014; 5():238. PubMed ID: 25484875
[TBL] [Abstract][Full Text] [Related]
8. 22q11.2 deletion carriers and schizophrenia-associated novel variants.
Balan S; Iwayama Y; Toyota T; Toyoshima M; Maekawa M; Yoshikawa T
Br J Psychiatry; 2014; 204():398-9. PubMed ID: 24482440
[TBL] [Abstract][Full Text] [Related]
9. Whole-Genome Sequencing and Integrative Genomic Analysis Approach on Two 22q11.2 Deletion Syndrome Family Trios for Genotype to Phenotype Correlations.
Chung JH; Cai J; Suskin BG; Zhang Z; Coleman K; Morrow BE
Hum Mutat; 2015 Aug; 36(8):797-807. PubMed ID: 25981510
[TBL] [Abstract][Full Text] [Related]
10. Schizophrenia Risk Mediated by microRNA Target Genes Overlapped by Genome-Wide Rare Copy Number Variation in 22q11.2 Deletion Syndrome.
Ying S; Heung T; Zhang Z; Yuen RKC; Bassett AS
Front Genet; 2022; 13():812183. PubMed ID: 35495153
[TBL] [Abstract][Full Text] [Related]
11. Rare coding variants as risk modifiers of the 22q11.2 deletion implicate postnatal cortical development in syndromic schizophrenia.
Lin JR; Zhao Y; Jabalameli MR; Nguyen N; Mitra J; ; Swillen A; Vorstman JAS; Chow EWC; van den Bree M; Emanuel BS; Vermeesch JR; Owen MJ; Williams NM; Bassett AS; McDonald-McGinn DM; Gur RE; Bearden CE; Morrow BE; Lachman HM; Zhang ZD
Mol Psychiatry; 2023 May; 28(5):2071-2080. PubMed ID: 36869225
[TBL] [Abstract][Full Text] [Related]
12. Whole-genome sequencing suggests mechanisms for 22q11.2 deletion-associated Parkinson's disease.
Butcher NJ; Merico D; Zarrei M; Ogura L; Marshall CR; Chow EWC; Lang AE; Scherer SW; Bassett AS
PLoS One; 2017; 12(4):e0173944. PubMed ID: 28430790
[TBL] [Abstract][Full Text] [Related]
13. Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome.
Prasad SE; Howley S; Murphy KC
Dev Disabil Res Rev; 2008; 14(1):26-34. PubMed ID: 18636634
[TBL] [Abstract][Full Text] [Related]
14. A neurogenetic model for the study of schizophrenia spectrum disorders: the International 22q11.2 Deletion Syndrome Brain Behavior Consortium.
Gur RE; Bassett AS; McDonald-McGinn DM; Bearden CE; Chow E; Emanuel BS; Owen M; Swillen A; Van den Bree M; Vermeesch J; Vorstman JAS; Warren S; Lehner T; Morrow B
Mol Psychiatry; 2017 Dec; 22(12):1664-1672. PubMed ID: 28761081
[TBL] [Abstract][Full Text] [Related]
15. Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease.
Butcher NJ; Marras C; Pondal M; Rusjan P; Boot E; Christopher L; Repetto GM; Fritsch R; Chow EWC; Masellis M; Strafella AP; Lang AE; Bassett AS
Brain; 2017 May; 140(5):1371-1383. PubMed ID: 28369257
[TBL] [Abstract][Full Text] [Related]
16. Risk gene-set and pathways in 22q11.2 deletion-related schizophrenia: a genealogical molecular approach.
Michaelovsky E; Carmel M; Frisch A; Salmon-Divon M; Pasmanik-Chor M; Weizman A; Gothelf D
Transl Psychiatry; 2019 Jan; 9(1):15. PubMed ID: 30710087
[TBL] [Abstract][Full Text] [Related]
17. Analyses of the associations between the genes of 22q11 deletion syndrome and schizophrenia.
Arinami T
J Hum Genet; 2006; 51(12):1037-1045. PubMed ID: 16969581
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs as the cause of schizophrenia in 22q11.2 deletion carriers, and possible implications for idiopathic disease: a mini-review.
Forstner AJ; Degenhardt F; Schratt G; Nöthen MM
Front Mol Neurosci; 2013 Dec; 6():47. PubMed ID: 24367288
[TBL] [Abstract][Full Text] [Related]
19. Association of COMT and PRODH gene variants with intelligence quotient (IQ) and executive functions in 22q11.2DS subjects.
Carmel M; Zarchi O; Michaelovsky E; Frisch A; Patya M; Green T; Gothelf D; Weizman A
J Psychiatr Res; 2014 Sep; 56():28-35. PubMed ID: 24853458
[TBL] [Abstract][Full Text] [Related]
20. Differential resting-state patterns across networks are spatially associated with Comt and Trmt2a gene expression patterns in a mouse model of 22q11.2 deletion.
Gass N; Peterson Z; Reinwald J; Sartorius A; Weber-Fahr W; Sack M; Chen J; Cao H; Didriksen M; Stensbøl TB; Klemme G; Schwarz AJ; Schwarz E; Meyer-Lindenberg A; Nickl-Jockschat T
Neuroimage; 2021 Nov; 243():118520. PubMed ID: 34455061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
